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Age-related hearing loss (ARHL) is a prevalent communication problem among senior 
citizens. Previous work (Tadros et al., 2008) has revealed genes which change their 
expression significantly with aging and hearing loss. However, this study is limited as it 
mainly focuses on apoptosis-related genes. Genes that regulate biological pathways other 
than apoptosis might also contribute to the development of age-related hearing loss, as 
suggested by some studies (Tadros et al., 2007; Souza et al., 2008). In order to 
circumvent this limitation and to better understand the underlying mechanisms of this 
communication problem, a free computational tool called Gene Set Enrichment Analysis 
(GSEA) is used to analyze the microarray data of aging cochlea and brain. Results show 
that most of the pathways which are up-regulated with aging/hearing loss in cochlea play 
a role in apoptosis and/or inflammation, suggesting that these two processes might be 
crucial for the development of ARHL. In contrast to the results from the cochlea, results 
for the aging brain indicate that cell cycle arrest is involved in deficits in the central 
auditory system with age.  
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APAF-1: apoptotic protease activating factor-1 
ARHL: age-related hearing loss 
AMI: acute myocardial infarction 
ATM: ataxia telangiectasia mutated 
Bcl-2: B-cell lymphoma 2 
BAX: Bcl2-associated X protein 
BLP: bacterial lipoprotein 
DD: death domain 
DISC: death inducing signal complex 
ES: enrichment score 
FDR: false discovery rate 
FADD: Fas-associate death domain  
GO: gene ontology 
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GSEA: gene set enrichment analysis 
IL-1R: Interleukine-1 receptor 
IRAK: IL-1R associated kinase  
JNK: c-Jun N-terminal kinase 
LPS: lipopolysaccharide 
MSigDB: molecular signature database 
NES: normalized enrichment score 
PAMPs: pathogen-associated molecular patterns 
PT: permeability transition 
PUMA: p53 up-regulated modulator of apoptosis 
RIP: receptor-interacting protein 
RMA: robust multi-array average 
ROS: reactive oxygen species 
TIR domain: Toll/interleukin-1 receptor domain 
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TIRAP: TIR-domain-containing adapter protein 
TNF: tumor necrosis factor 
TRADD: TNF-receptor associated death domain 
TRAFs: tumor necrosis factor receptor associated factors 
TIMs: TRAF-interacting motifs 
TLR: Toll-like receptor 
Th cells: T helper cells 
MyD88: myeloid differentiation factor 88 
NF-kB: nuclear factor-kB 
IkB: inhibitor of NF-kB 
IKK: IkB kinase 
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1.1 Age-related Hearing Loss 
In humans, age-related hearing loss (ARHL), or presbycusis, is a prevalent 
communication problem among senior citizens. It compromises the health of elderly 
persons and reduces the quality of their daily life, as it not only results in auditory 
deficiency, but also has psychological, physical and social consequences [1]. With the 
increased number of elderly people in our society, both in relative and absolute numbers, 
developing therapeutic treatments for ARHL becomes even more important, particularly 
in terms of reducing the load on our over-burdened health care system. As the therapeutic 
treatment of disease can be based on the understanding of the underlying cellular and 
molecular mechanisms behind it, numerous studies which focus on the pathological and 
physiological processes of ARHL have been conducted. 
CBA/CaJ mice is often used as the model organism for the study of aging in the central 
auditory system. After correcting for the differences in the lifespans of mice and men, it 




1.2 The Cochlea 
The cochlea, whose structure consists of the inner and the outer hair cells, their 
supporting cells and the stria vascularis, is an important part of the auditory system in the 
mouse and the human inner ear [4]. Studies show that structural changes of the cochlea 
during the aging process lead to age-related hearing loss [1]. For example, it is often 
noted that ARHL is consistently associated with a decline in the number of outer hair 
cells and a smaller decrease in the numbers of inner hair cells [5]. Other lines of 
investigation point to the pathology of the stria vascularis, the specialized cochlear organ 
that produces endolymph, as a key component of ARHL (Schmiedt, 1996; Suryadevara et 
al.,2001). Thus, study of the underlying biological changes that occur with age in the 
cochlea is crucial to understanding the mechanisms of ARHL. 
1.3 Apoptosis  
1.3.1 Apoptosis and Age-related Hearing Loss 
Study of ARHL is very difficult as it is an extremely complex system of processes 
involving the participation of multiple cellular pathways which are influenced by a 
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combination of different genetic and environmental factors [1]. It is highly speculated 
that apoptosis, the endogenous programmed cell death,  plays an important role in ARHL.  
1.3.2 Biological Significance of Apoptosis 
Apoptosis, described first by Kerr, Wyllie, and Currie in 1972, is a distinct form of cell 
death which helps to maintain homeostasis in multi-cellular biological systems. It is of 
great biological significance: on the one hand, appropriate apoptosis is the requirement 
for the normal functioning of a wide variety of processes ranging from immune reactions, 
embryonic development to hormone-dependent atrophy [6,7]; on the other hand, 
dysfunction (or dysregulation) of apoptosis (either too little or too much) is associated 
with a variety of human diseases. For example, insufficient apoptosis may result in 
cancer, autoimmune diseases as well as spreading of viral infections. On the contrary, 
excessive apoptosis is thought to play a role in AIDS, ischaemic disease and 
neurodegenerative disorders like Parkinson’s and Alzheimer’s Disease [7,8]. 
1.3.3 Intracellular Morphological Features of Apoptosis 
Cells undergo apoptosis following a series of controlled steps which eventually leads to 
cellular self-destruction in response to stimuli such as heat, radiation, hypoxia and 
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cytotoxic anticancer drugs [6,7]. The morphological changes of apoptosis include cell 
shrinkage (which is characterized by smaller cell size, dense cytoplasm and more tightly 
packed organelles), pyknosis (which results from chromatin condensation), karyorrhexis 
(fragmented nuclei), the plasma membrane blebbing and budding [4,6].  
1.3.4 Apoptosis and Necrosis 
Unlike necrosis, the unintentional form of cell death in which case inflammatory 
reactions are caused by the release of the cytoplasmic contents into the surrounding tissue 
as a result of disrupted cell membrane, the process of apoptosis is controlled in such a 
way that essentially, there is no inflammatory reaction associated with it nor does it cause 
damage to its surrounding cells [6,7]. This is largely due to the fact that apoptotic cells, 
which are quickly phagocytosed by macrophages or neighboring cells, do not release 
their cellular constituents into the adjacent tissues [6].  
As different as necrosis and apoptosis are in their mechanisms, they are still closely 
connected to each other as they share morphological features and biological networks in 
common. Although both necrosis and apoptosis can be induced by similar stimuli, which 
one is going to be induced in cells depends largely on the degree and nature of the stimuli 
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[6]. Interestingly, there is even evidence indicating that an ongoing apoptotic process can 
be converted into a necrotic process under certain conditions [9,10].   
1.3.5 Mechanisms of Apoptosis 
Apoptosis is an extremely complex and sophisticated process. Generally, there are two 
types of apoptotic pathways: extrinsic (or death receptor) pathway and intrinsic (or 
mitochondrial) pathway. They converge at the final stage of apoptosis, named the 
execution phase, which starts with the activation of caspases [6].  
1.3.5.1 Extrinsic Pathway 
The extrinsic pathway is caused by the binding of specific ligands called pro-apoptotic 
ligands (such as Fas, TNF alpha and TRAIL) with death receptors that are located on the 
cell surface. Following ligand binding, receptors cluster and undergo the conformational 
changes. This induces a death domain and allows the recruitment of adaptor proteins such 
as Fas-associated death domain protein (FADD) or TNF-receptor associated death 
domain protein (TRADD) [8]. It then results in the formation of the protein complex, 
death inducing signal complex (DISC) and the recruitment of caspase 8. After caspase 8 









                                                   Execution Phase 
Figure 1. Extrinsic pathway of apoptosis 
1.3.5.2 Intrinsic Pathway 
The intrinsic pathway can be initiated by stimuli that act either negatively (withdrawal of 
cell survival signal, absence of certain growth factors) or positively (radiation, toxins, 
hypoxia, hyperthermia, viral infection, free radicals) inside the cells [6]. Upon 
stimulation, the mitochondrial inner transmembrane potential is reduced and the 
mitochondrial permeability transition (PT) pore is opened. This results in the release of 
pro-apoptotic proteins such as cytochrome c from the mitochondrial intermembrane space 
into the cytosol [6]. After that, cytochrome c binds the adaptor apoptotic protease 
activating factor-1 (Apaf-1) and procaspase-9, leading to the formation of a large multi-





protein complex called “apoptosome” which then causes the activation of caspase 9 and 
initiation of execution phase [6,8]. 
The intrinsic apoptosis pathway is regulated by the B-cell lymphoma 2 (Bcl-2) family of 
proteins which can be divided into two groups: pro-apoptotic and anti-apoptotic proteins. 
Pro-apoptotic proteins such as Bad, Bax and Bid tend to induce apoptosis while anti-
apoptotic proteins such as Bcl-2, Bcl-X tend to resist to apoptosis [8]. Whether apoptosis 










                                                                              Execution Phase 












1.3.5.3 Execution Phase 
Caspases, a family of proteins belonging to a group of enzymes known as cysteine 
proteases are the central executors and mediators of the execution phase of apoptosis [8]. 
There are two types of caspases: initiator caspases and effector (or executor) caspases 
which stay inactive within cells until being activated. Initiator caspases such as Caspase-
2,8,9,10 which reside upstream in the pathway and are activated by the induction of  
either extrinsic pathways or intrinsic pathways or both, will in turn, activate  downstream 
effector caspases such as Caspase-3,6,7. The activation of effector caspases, then leads to 
the cleavage of key cellular proteins such as cytoskeletal proteins, and this accounts for 














2. Data and Methods 
2.1 Description of the Mouse Cochlea and Brain 
Microarray Data 
Data used in this study are microarray mouse gene expression data from the cochlea and 
the inferior colliculus which are provided by Dr. Frisina’s Lab. CBA/CaJ mice were used 
as the model organism for this study as this strain shows a progressive hearing loss that 
parallels that of presbycusis in humans, when accounting for the lifespan of each species 
(Frisina and Walton, 2006). Based on age and functional hearing measurements obtained 
from the auditory brainstem response recordings (ABR thresholds) and the otoacoustic 
emissions (DPOAE amplitudes),  the whole sample set can be divided into four groups: 
young adult control with good hearing, middle-aged with good hearing, old with mild 
presbycusis and old with severe presbycusis [4]. One Affymetrix M430A high-density 
oligonucleotide array set containing 22,600 probe sets which analyze the expression of 
over 14,000 mouse genes was used for each sample [4]. Full experimental details can be 
found in Sherif F. Tadros, Mary D’Souza, Xiaoxia Zhu, Robert D. Frisina’s paper: 
Apoptosis-related genes change their expression with age and hearing loss in the mouse 
cochlea, Apoptosis (2008) [4].  
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2.2 Data Normalization 
The goal of high density oligonucleotide arrays is to detect differences of mRNA 
expression in response to genetic and environmental differences, which is also referred to 
as interesting variation [14]. However, non-biologically originated variations, also known 
as obscuring variations (or systematic variations) which are introduced during sample 
preparation, manufacture of the arrays, and the processing of the arrays (labeling, 
hybridization, and scanning) also exist and could mislead interpretation of the results [14]. 
Thus, before proceeding with a formal statistical analysis, obscuring variations should be 
reduced first by applying preprocessing steps such as data normalization. In this study, 
data is normalized by implementing the Robust Multi-array Average (RMA) method of 
Affymetrix Oligonucleotide Arrays R package, which is freely available 
(http://www.bioconductor.org). RMA is a normalization method which consists of three 
preprocessing steps: background correction, quantile normalization and a final 
summarization. It has been shown by other studies (Irizarry et al. 2003) that RMA 
outperformed AvDiff, the Li and Wong model-based expression index, dChip and MAS 
5.0 in the following aspects: first of all, RMA shows higher precision without 
compromising its  accuracy; second, estimations of fold change provided by RMA are 
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more consistent; third, results provided by RMA shows higher specificity and sensitivity, 
when using fold change analysis to detect differential expression patterns [12,14].  
2.3 GSEA 
2.3.1 Advantages Using GSEA  
Gene Set Enrichment Analysis (GSEA) is a powerful analytical method for the 
interpretation of gene expression data and is incorporated into a software package that 
can be downloaded freely (http://www.broadinstitute.org/gsea). Traditional single gene 
analysis such as ANOVA, although useful, is limited by its low overlapping rate between 
different studies, its failure to capture significant genes with unifying biological themes 
as well as its deficiency to reveal underlying relationships between those genes. GSEA is 
designed to circumvent such limitations by analyzing gene expression data at the level of 
gene sets.  
2.3.2 Overview  
Based on gene sets which are defined based upon prior biological knowledge, such as 
published information about biochemical pathways or co-expression patterns in previous 
experiments and samples that fall into two classes, GSEA tries to find gene sets that are 
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associated with one of the two classes by determining whether the members of a gene set 
tend to occur toward the top (or bottom) of the class list [15].   
2.3.3 Methods  
There are three steps for the GSEA method. In the first step, an Enrichment Score (ES) is 
calculated to measure how well a given gene set is overrepresented towards the top or 
bottom of the entire ranked list. Then, the nominal P value which reflects the statistical 
significance of the ES is estimated using a phenotype-based permutation test. In the last 
step, ES is normalized to account for the size of each gene set, resulting in normalized 
enrichment score (NES) [16]. A false discovery rate (FDR) is also calculated with NES 
correspondingly.  
2.3.4 Leading Edge Analysis 
Even in gene sets with high ES, not all their members are up-regulated. Leading edge 
analysis is designed to find out the leading edge subset, a subset of genes that contribute 
most to the ES within a high scoring gene set [15].  Leading edge analysis might also 
help to reveal gene sets with the same biological function on the basis of common leading 
edge subsets that are shared by those high scoring gene sets.  
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2.3.5 Evaluation of Performances 
In order to evaluate the performance of GSEA, several studies have been conducted (A. 
Subramanian et al., 2003). In the first study (Male vs. Female Lymphoblastoid Cells), 
gene sets on chromosome Y are found to be up-regulated in male samples as expected. 
Alternatively, X inactivation genes and female reproductive tissue expressed genes are 
found to be up-regulated in female samples. Results of two other studies analyzed by 
GSEA (p53 Status in Cancer Cell Lines and Acute Leukemias) are also biologically 
meaningful. In the last study, two lung cancer gene expression data sets obtained 
independently by different study groups (Boston group and Michigan group) are analyzed 
with GSEA as well as single gene analysis and their results are also compared. The study 
shows that similarities between results analyzed with GSEA of the two data sets are 
significantly higher than those analyzed with single gene analysis. Thus, it can be 
concluded that GSEA is superior to single gene analysis in both its reproducibility and 
interpretability  [15]. 
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2.3.6 Molecular Signature Database (MSigDB) and Biocarta 
Since the performance of GSEA depends largely on how representative the given gene 
sets are to the actual biological processes, the definition and curation of such gene sets 
are of great significance [16]. Molecular Signature Database (MSigDB) which contains a 
collection of gene sets has been created on the GSEA website  to assist its users. Gene 
sets can be generally divided into five categories: C1 positional gene sets which represent 
genes in the same chromosome or cytogenetic band; C2 curated gene sets which originate 
from publicly available databases of metabolic and signaling pathways such as KEGG, 
BioCarta and PubMed; C3 motif gene sets which are based on conserved regulatory 
motifs from comparative analysis of different species; C4 computational gene sets which 
is defined as sets of genes in expression neighborhoods of cancer-related genes; C5 GO 
gene sets which consist of genes annotated by the same GO terms (Subramanian, Tamayo, 
et al., 2005) [16].  The choice of specific gene sets should be based on data type and the 
goal of the study.  
BioCarta, one of the C2 curated gene sets, is selected as the database for gene sets in this 
study. It seems to be the most appropriate choice for the present investigation, since it 
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maintains a good collection and classification of cellular pathways, including pathways 













3. Results  
Since both old mice with mild presbycusis and old mice with severe presbycusis had a 
small sample size in the gene microarray data set of the present study, they are combined 
together as a single “old mice group” in order to have sufficient statistical power to carry 
out the study. Comparisons such as young mice versus old mice and middle-aged mice 
versus old mice are conducted using GSEA for both cochlea and brain gene microarray 
data. Leading edge analysis is then conducted for gene sets that are significantly up-








3.1 GSEA Result for Cochlear Data 
The result of GSEA analysis for young mice versus old mice can be found in Table 1. 
Ten pathways are found to be significantly up-regulated in old mice (NOM p value < 
0.05, FDR < 0.3): Toll-Like Receptor Pathway (TOLL), Signal transduction through 
IL1R (IL1R), TNFR1 Signaling Pathway (TNFR1), Signaling of Hepatocyte Growth 
Factor Receptor (MET), NF-kB Signaling Pathway (NF-kB), TNFR2 Signaling Pathway 
(TNFR2), TNF/Stress Related Signaling (Stress), FAS Signaling Pathway (CD95), 
Inhibition of Cellular Proliferation by Gleevec (GLEEVEC) and Induction of apoptosis 
through DR3 and DR4/5 Death Receptors (DEATH).  
Symbol NOM p-value FDR q-value Pathway Description 
TOLL 0.002 0.040 Toll-Like Receptor Pathway  
IL1R 0.002 0.034 Signal transduction through IL1R 
TNFR1 0.023 0.147 TNFR1 Signaling Pathway 
MET 0.008 0.240 Signaling of Hepatocyte Growth Factor 
Receptor 
NFKB 0.022 0.238 NF-kB Signaling Pathway 
TNFR2 0.010 0.225 TNFR2 Signaling Pathway 
STRESS 0.029 0.258 TNF/Stress Related Signaling 
FAS 0.024 0.282 FAS Signaling Pathway (CD95) 
GLEEVEC 0.022 0.250 Inhibition of Cellular Proliferation by 
Gleevec 
DEATH 0.049 0.284 Induction of apoptosis through DR3 and 
DR4/5 Death Receptors 
Table 1. Gene sets that are up-regulated in old mice (p < 0.05, FDR < 0.3). Comparisons 
are conducted between young mice and old mice for the cochlear data. 
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From these results, it can be inferred that most of the pathways which are found to be up-
regulated in old mice are closely connected with each other and fall into two major 
groups: Toll/IL-1R and TNF super-family related pathways.  
 
Figure 4. Leading edge analysis for the ten gene sets in Table 1. 
Leading edge analysis is conducted for the ten gene sets in Table 1. Genes that appear at 
least twice are shown in Figure 4. Complete result for this analysis can be found in 
Appendix. Genes such as MAP3K1, JUN, CFLAR are well known apoptosis genes and 
showed significant gene expression differences in previous study (Tadros et al., 2008). 
TRADD and CRADD are also apoptosis-related. Although not found by previous study, 
they are statistically significant according to the result of this leading edge analysis. 




























Symbol NOM p-value FDR q-value Pathway Description 
INTRINSIC 0.000 0.012 Intrinsic Prothrombin Activation 
Pathway 
IL6 0.004 0.103 IL 6 signaling pathway 
TOLL 0.010 0.154 Toll-Like Receptor Pathway 
NKT 0.024 0.166 Selective expression of chemokine 
receptors during T-cell polarization 
IL2RB 0.008 0.145 IL-2 Receptor Beta Chain in T cell 
Activation 
IL12 0.027 0.130 IL12 and Stat4 Dependent Signaling 
Pathway in Th1 Development 
IL2 0.024 0.169 IL2 Signaling Pathway 
NGF 0.030 0.276 Nerve growth factor pathway (NGF) 
EPO 0.043 0.271 EPO Signaling Pathway 
MET 0.031 0.246 Signaling of Hepatocyte Growth Factor 
Receptor 
Table 2. Gene sets that are up-regulated in old mice (p < 0.05, FDR < 0.3). Comparisons 
are conducted between middle-aged mice with good hearing and old mice from cochlea 
data. 
The result of GSEA analysis for middle-aged mice with good hearing and old mice can 
be found in Table 2. Ten pathways are found to be significantly up-regulated in old mice 
(NOM p value < 0.05, FDR < 0.3): Intrinsic Prothrombin Activation Pathway 
(INTRINSIC), IL 6 signaling pathway (IL6), Toll-Like Receptor Pathway (TOLL), 
Selective expression of chemokine receptors during T-cell polarization (NKT), IL-2 
Receptor Beta Chain in T cell Activation (IL2RB), IL12 and Stat4 Dependent Signaling 
Pathway in Th1 Development (IL12), IL2 Signaling Pathway (IL2), Nerve growth factor 
pathway (NGF), EPO Signaling Pathway (EPO), Signaling of Hepatocyte Growth Factor 




Figure 5. Leading edge analysis for the ten gene sets in Table 2. 
Leading edge analysis is conducted for the ten gene sets in Table 2. Genes that appear at 
least twice are shown in Figure 5. Complete result for this analysis can be found in 
Appendix. Genes such as CXCR3, IL12A, IL12B, IL12RB2, IL18R1 and STAT3 are 
































3.2 GSEA Result for Brain Data 
Symbol NOM p-value FDR q-value Pathway Description 
P53 0.000 0.050 p53 Signaling Pathway 
NKCELLS 0.004 0.042 Ras-Independent pathway in NK cell-
mediated cytotoxicity 
P38MAPK 0.004 0.032 p38 MAPK Signaling Pathway 
AMI 0.004 0.043 Acute Myocardial Infarction 
CSK 0.004 0.035 Activation of Csk by cAMP-dependent 
Protein Kinase Inhibits Signaling 
through the T Cell Receptor 
ATM 0.020 0.136 ATM Signaling Pathway 
NKT 0.030 0.140 Selective expression of chemokine 
receptors during T-cell polarization 
G2 0.033 0.161 Cell Cycle: G2/M Checkpoint 
G1 0.043 0.210 Cell Cycle: G1/S Check Point 
IL1R 0.049 0.189 Signal transduction through IL1R 
P53HYPOXIA 0.027 0.178 Hypoxia and p53 in the Cardiovascular 
system 
RACCYCD 0.032 0.207 Influence of Ras and Rho proteins on 
G1 to S Transition 
Table 3. Gene sets that are up-regulated in old mice for brain (p < 0.05, FDR < 0.3). 
Comparisons are conducted between middle-aged mice with good hearing and old mice 
for gene microarray data from the central auditory system. 
The same comparisons are conducted for brain data. For the comparison young mice 
versus old mice, no individual gene set meets the threshold for statistical significance. 
The result of GSEA analysis for middle-aged mice with good hearing versus old mice can 
be found in Table 3. Twelve pathways are found to be significantly up-regulated in old 
mice (NOM p value < 0.05, FDR < 0.3): p53 Signaling Pathway (P53), Ras-Independent 
pathway in NK cell-mediated cytotoxicity (NKCELLS), p38 MAPK Signaling Pathway 
(P38MAPK), Acute Myocardial Infarction (AMI), Activation of Csk by cAMP-
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dependent Protein Kinase Inhibits Signaling through the T Cell Receptor (CSK), ATM 
Signaling Pathway (ATM), Selective expression of chemokine receptors during T-cell 
polarization (NKT), Cell Cycle: G2/M Checkpoint (G2), Cell Cycle: G1/S Check Point 
(G1), Signal transduction through IL1R(IL1R), Hypoxia and p53 in the Cardiovascular 
system (P53HYPOXIA), Influence of Ras and Rho proteins on G1 to S Transition 
(RACCYCD).  
P53, P53HYPOXIA, ATM and P38 MAPK are all closely associated with intrinsic 
apoptosis pathways. G1, G2 and RACCYCD pathways are responsible for cell 
proliferation.  
 



























Leading edge analysis is conducted for the ten gene sets in Table 3. Genes that appear at 
least twice are shown in Figure 6. Complete result for this analysis can be found in 
Appendix. CDKN1A, ATM, TGFB2 and CHEK2 are involved in cell cycle arrest.  
4. Discussion 
4.1 Toll/IL-1R Pathway and Innate Immunity 
Innate immunity is an evolutionarily conserved protective mechanism in multi-cellular 
organisms that provides the first line of defense for the host against invading pathogens. 
It is triggered upon recognition of pathogen-associated molecular patterns (PAMPs) such 
as lipopolysaccharide (LPS) and bacterial lipoprotein (BLP) by pattern recognition 
receptors such as Toll-like receptor (TLR) and interleukin-1 receptor (IL-1R) [22]. 
Although previously being considered to be non-specific, innate immunity is later proved 
to have some specificity since it can not only detect infections, but is also capable of 
recognizing the type of invading pathogens [22]. Furthermore, it is a pre-requisite for the 
activation of acquired immunity [18].    
Pathways that are pertinent to innate immunity include Toll-Like Receptor Pathway, 
signal transduction through IL1R and nuclear factor-kB (NF-kB) Signaling Pathway.  
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NF-kB plays a vital role in host defense mechanisms and it can be induced upon 
activation of Toll or IL-1R signaling pathways [20].  
Although the extracellular domains of TLRs and IL-1Rs are significantly different, they 
have highly similar cytoplasmic domains, which is known as Toll/interleukin (IL)-1 
receptor domain (TIR domain) [19]. Toll-Like Receptor Pathway and IL-1R Pathway are 
homologous transduction signaling pathways. Upon stimulation, Toll and IL-1R can 
induce the nuclear factor kB (NF-kB) pathway through MyD88/IRAK/TRAF6 pathway 
[20]. Myeloid differentiation factor 88 (MyD88) functions as the common mediator for 
Toll/IL-1R inducing NF-kB and apoptosis initiated by TLR2 [21,23]. MyD88 contains an 
N-terminal death domain and a C-terminal TIR domain [22]. The death domain interacts 
with the death domain of IL-1R-associated kinase (IRAK) and the TIR domain combines 
with the TIR domains of Toll and the IL-1R. IRAK is then activated, auto-
phosphorylated [22]. After its disassociation from MyD88, it associates with another 
adaptor protein, called tumor necrosis factor (TNF) receptor-associated factors 6 (TRAF6) 
[22]. NF-kB pathways is activated after the phosphorylation of IkB protein  by IKK 
kinases [22]. However, MyD88 is not indispensible for the activation of NF-kB since NF-
kB can also be activated through a MyD88-independent pathway initiated by TLR3 and 
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TLR4, the mechanism of which is not fully understood [20]. It is shown that this MyD88 
independent signaling is mediated by a novel adaptor protein called TIR-domain-
containing adapter protein (TIRAP) (Janssens et al., 2002) [20]. MyD88 dependent and 
independent pathways converge at the formation of the IKK complex (Akira et al., 2001) 
[18]. 
 
Figure 7. Toll/IL-1R signaling pathway leading to NF-kB and apoptosis initiated by 













It is reported that the apoptotic signaling pathway can be activated by TLR2 via 
MyD88/FADD/Caspase 8 pathway (Aliprantis et al., 2000) [23]. FADD interacts with 
MyD88 through their death domains (DDs) [20]. FADD can then bind with pro-caspase 8, 
resulting in oligomerization, enzyme maturation and activation of apoptosis (Martin et al., 
1998; Muzio et al., 1998b) [23]. Although involvement of IL-1 in apoptosis has been 
reported in diabetes mellitus (Sjoholm, 1998) and acute neurodegeneration (Rothwell et 
al.,1997), it is still not clear whether IL-1 mediates cell death through the 
MyD88/FADD/caspase 8 pathway [23] 
4.2 NF-kB, Inflammation and Apoptosis  
NF-kB signaling is the master regulator of inflammation. Before activated, NF-kB 
complexes bind to the inhibitory IkB proteins and stay in the cytoplasm [37]. Once 
stimulated, IkB proteins are phosphorylated  and the NF-kB complex is translocated to 
the nucleus [37]. This leads to the activation of genes which are responsible for the 
induction of inflammation.  
NF-kB signaling also can have anti-apoptotic actions in several ways [20,23]. First of all, 
inhibitors of apoptosis (IAPs) such as c-FLIP, Bcl-xL, c-IAP1, c-IAP2 and XIAP are 
activated by NF-kB signaling [37]. Furthermore, c-Jun N-terminal kinase (JNK), a well-
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known kinase mediating apoptotic signals, can also be inhibited by NF-kB [37]. However, 
NF-kB has also been implicated to promote pro-apoptotic responses and induce cell death 










                                               
 











4.3 TNF Superfamily, Induction of Apoptosis and NF-kB 
Members of the TNF superfamily are known for their ability to regulate apoptosis, cell 
proliferation, survival and differentiation [24]. The existence of as many as 30 members 
of the TNF receptor superfamily has been revealed to date. Interestingly, it is shown that 
all members of the TNF superfamily activate NF-kB, which can suppress apoptosis.  
TNFR1 Signaling Pathway (TNFR1), TNFR2 Signaling Pathway (TNFR2), TNF/Stress 
Related Signaling (Stress), FAS Signaling Pathway (CD95) and Death Pathway are 
pathways activated by members of the Tumor necrosis factor (TNF) super-family. The 
ligands, receptors and biological functions of these pathways can be found in Table 3.  
Pathway Ligand Receptor Induction of Apoptosis Induction of NF-kB 
TNFR1 TNF-α TNFR1 Yes Yes 
TNFR2 TNF-β TNFR2 Yes Yes 
TNF TNF-α TNFR1 Yes Yes 
Fas FasL Fas Yes Yes 
Death VEGI DR3 Yes Yes 
Death TRAIL DR4, DR5 Yes Yes 




Figure 9. TNF signaling pathways leading to apoptosis and NF-kB 
Note that these pathways function upstream for the activation of apoptosis, NF-kB, or 
both.  The underlying mechanisms for the induction of apoptosis and NF-kB by the TNF 
superfamily related pathways will be discussed next and a graph that simplifies the whole 
process can be found in figure 9. 
There are two types of TNF receptors: those that have a death domain (DD) in their 
cytoplasmic portion and those do not have a DD. TNFR1, Fas, DR3, DR4 and DR5 
contain a DD and belong to the first type. They can lead to apoptosis by recruiting their 
DD with FADD and FLICE. TNFR1 induce apoptosis in slightly different way since its 



















also be induced by the TNF family through mitochondrial dependent intrinsic pathways 
shown in Figure 9. TNFR2 does not have a DD and thus belongs to the second type. It 
has been shown that TNFR2 is still be able to mediate apoptosis through a DD 
independent way, the specific mechanism of which remains to be revealed (Ramesh et 
al.,2003; Haridas et al.,1998) [25,26].  
NF-kB can be activated by all members of the TNF superfamily and this is mediated by a 
family of adaptors called tumor necrosis factor receptor associated factors (TRAFs) [27]. 
TNFRs associate with TRAFs through a conserved cytoplasmic motif termed TRAF-
interacting motifs (TIMs). Receptor-interacting protein (RIP) is then recruited and this 


















Figure 10. T-cell polarization 
T cells, also known as lymphocytes, are a type of white blood cells that play an important 
role in adaptive immunity. Based on biological functions, T cells can be divided into 
several subsets such as T helper cells, cytotoxic T cells, memory T cells and natural killer 
T cells. T helper cells (Th cells) which assist in the immune response by secretion of 
small signaling protein molecules such as cytokines, can be differentiated into two major 
subgroups: T helper subset 1 cells (Th1) and T helper subset 2 cells (Th2).  















Polarization of T helper cells depends largely on the type of cytokines during priming 
(See Figure 10). For instance, IL-12 and IFN-γ facilitate polarization of Th1 cells 
whereas IL-4 tend to promote differentiation of Th2 cells [36]. The two different types of 
cells are responsible for the protection against different pathogens. Th1 cells secrete IL-2 
and provide protection for the host from intracellular pathogens. On the other hand, Th2 
cells which secrete IL-4 and IL-5, are involved in the protection against extracellular 
pathogens [36]. 
Pathways such as IL12 and IL2 are up-regulated in old mice, indicating Th1 polarization 
is more likely than Th2 polarization in this case. Interestingly, for the analysis of young 
mice versus old mice, most of the pathways seem to be involved in innate immunity 
whereas for the analysis of middle-aged mice versus old mice, pathways are more 
connected to adaptive immunity. This is reasonable since innate immunity is activated 
before the adaptive immunity. Furthermore, activation of innate immunity is also 





















Figure 11. p53 pathway activate apoptosis, cell cycle arrest and cell senescence 
The p53 signaling pathway can be activated in response to both intrinsic and extrinsic 
stresses such as DNA damage, hypoxia and oncogenic stimulation within cells [28,29]. 


















pathways: cell cycle arrest, cell senescence or apoptosis [28]. Which one of the three 
programs is initiated within cells depends on a wide variety of factors, ranging from the 
nature of the stress signal, the types and location of the protein modifications on the p53 
protein, to the pattern of gene expression in the specific tissue [28]. A graph that 
simplifies mediation of the p53 signaling pathway can be found in figure 11.      
Ataxia telangiectasia mutated (ATM) has been reported to act upstream of p53 signaling 
pathways in an ionizing radiation initiated signal transduction study (Canman et al., 1998) 
[30]. In response to DNA damage, p53 is phosphorylated by ATM kinase, leading to the 
activation of downstream genes that regulate cell cycle checkpoints or apoptosis [31]. 
P38MAPK, another activator of p53, has been shown to be able to strengthen p53 activity, 
leading to cell cycle arrest or apoptosis (Takekawa et al, 2000) [32]. 
The p53 signaling pathways mediate apoptosis through both extrinsic and intrinsic 
pathways. Intrinsic apoptosis pathways are promoted when p53 interacts with 
mitochondria, up-regulating reactive oxygen species (ROS) and pro-apoptotic genes such 
as BCL2-associated X protein (BAX), p53 up-regulated modulator of apoptosis (PUMA) 
[33]. This results in cytochrome c release and activation of intrinsic apoptosis pathways. 
Extrinsic pathways of apoptosis are also mediated by p53. Death receptors such as 
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Fas/CD95 and DR5 are activated by p53 and this leads to the activation of extrinsic 
pathway of apoptosis [34].  
Cells may arrest at cycle checkpoint to allow time for damage repair when exposed to 
genotoxic stress. In case that the damage is too severe to be repaired, the cell will 
undergo apoptosis. It is a protective mechanism that prevents further cellular damage. At 
least two checkpoints have been found: one at G1/S and the other at G2/M [35]. G1/S 
prevents damaged DNA from replication whereas G2/M is inhibited by damaged 
replicated DNA [35]. Evidence shows that p53 plays an important role in the G1 
checkpoint since it is required for the activation of G1/S transition (Kastan, et al., 1991; 
Kuerbitz et al.,1992). P53 might be also involved in G2/M transition although it is not 
required.  
4.6 Differences Between Brain and Cochlear Pathways  
As discussed previously, one factor that might affect a cell’s decision to undergo cell 
cycle arrest versus apoptosis is the cell type involved. Cells from different tissues might 
have different fates even in response to the same kind of stress signal. Thus, it is not 
surprising that pathways which are significantly up-regulated in old mice for brain tissue 
of the central auditory system are different from that for cochlear tissue samples. It seems 
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that up-regulated pathways in old mice for the cochlea such as TNFR1, TNFR2, STRESS, 
FAS and DEATH are well studied pathways leading to apoptosis. This might be evidence 
indicating cochlea cells undergo apoptosis involving cellular pathways common to other 
aging neural system. For brain, pathways such as G1, G2 and RACCYCD are 
significantly up-regulated in old mice. This might implicate the involvement of old brain 
cells in cell cycle arrest. However, it is not known whether this is due to tissue specificity 
or other, yet unidentified differences between the aging cochlea and aging auditory 





GSEA is a powerful tool that allows us to analyze microarray data at the level of gene 
sets. This helps us to interpret results in a biologically meaningful way rather than 
struggling with a long list of genes that are up- or down-regulated with age or hearing 
loss, without unifying themes or biologically-relevant ways to categorize the data.     
Results of the present study are in accordance with those of a previous study  (Tadros et 
al., 2008), increasing the reliability of the current findings. For instance, genes that 
showed significant expression differences for the cochlea samples of all the subject 
groups such as members of TNF and TNF receptor family, Caspase family members and 
NF-kB related genes, are also important components of pathways which are implicated to 
be up-regulated in old mice, as previously discovered by Tadros et al. using different 
biostatistical data analysis approaches.   
For the cochlea, most of the pathways identified in the present investigation seem to 
induce apoptosis and/or immune responses. Pathways regulating innate immunity seems 
to be significantly different for the analysis of young mice versus old mice, whereas 
pathways regulating adaptive immunity are significantly different for the analysis of 
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middle-aged mice versus old mice. This is in consistent with the fact that, across the 
lifespan, activation of innate immunity is required before the activation of adaptive 
immunity. Differences between results for the brain and cochlea may indicate tissue 
specificity concerning cell fate. It seems that cochlea cells are more likely to undergo 
apoptosis whereas brain cells tend to undergo cell cycle arrest; however, further 




6. Future Works 
Pathways that induce apoptosis and NF-kB are both found to be significantly up-
regulated with aging/hearing loss. Thus, it is quite possible that there is a balance 
between apoptosis and inflammation. How this balance is maintained might be crucial for 
the understanding of mechanisms of age-related hearing loss, for both the inner ear and 
central auditory system.  
Since apoptosis pathways might play an important role in age-related hearing loss, 
inhibition of apoptosis might be a potential way to prevent or treat age-related hearing 
loss. However, this is limited by its harmful side effects since apoptosis is crucial for the 
maintenance of proper function of the organism, i.e., preventing oncogenesis. Thus, it is 
important to find the specific targets for age-related hearing loss that can lead to the 
discovery of effective therapies for this disease.  
In the short term, future work could focus on the construction of genetic regulatory 
networks for apoptosis pathways using statistical methods such as Boolean Networks and 
Bayesian Networks. This might provide us deeper insights into interactions between 
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apoptosis related genes and their roles in the development and progression of age-related 
hearing loss.   
 Another research direction could be the comparison of regulation of pathways between 
brain and cochlea. It is expected that differences in regulation of pathways between brain 
and cochlea exist due to tissue specificity and cell type differences in these two levels of 
the mammalian auditory system. Results of such an investigation would reveal that cells 
in the cochlea and brain might have different fates. Cochlea cells are more likely to 
undergo apoptosis whereas brain cells, might choose to undergo cell cycle arrest, as 
suggested, by the present study. Understanding of this tissue specificity might help us to 
find biomarkers and potentially therapeutic agents, that when their pathways are blocked, 
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Appendix: Leading edge analysis 
This appendix lists the complete result of leading edge analysis.  























































Table 4. The result of leading edge analysis for the ten gene sets that are up-regulated in 
old mice for the GSEA analysis young mice versus old mice from cochlea samples. 
 





























































Table 5. The result of leading edge analysis for the ten gene sets that are up-regulated in 









































Table 6. The result of leading edge analysis for the twelve gene sets that are up-regulated 
in old mice for the GSEA analysis young mice versus old mice from brain samples. 
 
